Viridian Therapeutics (NASDAQ:VRDN) Posts Earnings Results, Hits Expectations
MarketBeat
Viridian Therapeutics (NASDAQ:VRDN - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($1.00) earnings per share for the quarter, meeting the consensus estimate of ($1.00). Viridian Therapeutics had a negative net margin of 112,806.88% and a negative return on equity of 72.85%. The firm had revenue of $0.08 million for the quarter, compared to analysts' expectations of $0.05 million. During the same quarter last year, the company posted ($0.81) EPS. The business's quarterly revenue was up 4.2% on a year-over-year basis.
NASDAQ:VRDN